Skip to content
Review

Stroke Heart Syndrome: Neuroimmune and Metabolic Crosstalk with Conceptual Approaches for Precision Therapeutics.

Aug 2026 · Cardiovascular Drugs and Therapy · 1 citation · 44 references
Medicine

TL;DR

This review proposes a hypothesis-generating conceptual framework that categorizes SHS into three endophenotypes, including neurogenic arrhythmic (Type I), inflammatory thrombotic (Type II), and metabolic remodeling (Type III), and potential phenotype-specific interventions include beta blockers for neural stabilization, NETs degradation for immunomodulation, and metabolic pathway antagonists.

View source

Similar papers

Review Open access Aug 2026

Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies

Renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, finerenone, and glucagon-like peptide-1 receptor agonists improve cardiorenal outcomes and have plausible anti-inflammatory actions, although inflammatory mediation remains unproven.

Aris Tsalouchos, P. Dattolo · 0 citations
Review Open access Aug 2026

TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity.

This review systematically delineates the spatiotemporal dynamics and functional duality of TREM2+ macrophages across major cardiovascular conditions, and further evaluates the current evidence and limitations of soluble TREM2 (sTREM2) as a candidate biomarker and critically appraises translational strategies targeting...

Ke Yang, Xue-Fang Ma, Bin-Yan Wang et al. · 1 citation
Review Jul 2026

Chronic kidney disease‑associated encephalopathy: Clinical features, pathomechanisms and emerging therapeutic strategies (Review).

The present review systematically outlines the clinical manifestations, core pathogenic mechanisms and emerging therapeutic strategies for CKD‑associated encephalopathy, and the targeted interventions on the gut‑kidney‑brain axis.

Nanling Zeng, Ling Jiang, Yang Zhang et al. · 0 citations
Review Open access Jul 2026

Central neuroendocrine dysregulation in ischaemic stroke sequelae: pathophysiological mechanisms—a narrative review

This review analyzes the adverse impact of HPA axis dysregulation on post-stroke outcomes across disease phases and elucidating these neuroendocrine-immune interactions provides a novel pathophysiological framework for understanding post-stroke multidimensional complications.

Han Gong, Dan Liu, Xiang-Zheng Wang et al. · 0 citations
Review Open access Jul 2026

Gut microbiota-mediated neuroinflammation following stroke: mechanisms and intervention strategies

The gut microbiota modulates the onset and progression of post-stroke neuroinflammation through multidimensional mechanisms via the “immune-neuro-endocrine” feedback pathway at multiple levels at multiple levels.

Lili Teng, Minmin Wu, Wenjing Song et al. · 0 citations
Review Open access Jul 2026

Brain heart crosstalk after ischemic stroke toward a unified framework for pathophysiology and precision medicine

A testable precision medicine paradigm integrating multimodal biomarkers to identify high risk individuals and guide targeted interventions is proposed to improve long term outcomes in this vulnerable population of stroke patients.

Peng-Peng Li, Yang-Yang Gao, Wei Liu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.